Pertussis (Whooping Cough) – Comprehensive Medical Guide

Overview

Pertussis, commonly known as whooping cough, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. It is characterized by severe, spasmodic coughing fits that often end with a “whoop” sound as the person gasps for air. Though vaccination has dramatically reduced incidence in many high‑income countries, pertussis remains a global health problem, especially for infants and those who are unvaccinated or under‑immunized.

• Who it affects: All ages can contract pertussis, but infants <1 year old are at highest risk for severe disease and death.
• Prevalence: In the United States, the CDC reported 18,542 cases in 2022, a 28 % increase from the prior year, with the highest rates in children <7 years and adolescents who missed booster doses. Worldwide, the WHO estimates 30–50 million cases and 160,000 deaths annually, the majority in low‑resource settings.
• Transmission: Spread occurs through respiratory droplets when an infected person coughs or sneezes. The bacteria can survive on surfaces for a few hours, but droplet spread is the main route.

Symptoms

Pertussis progresses through three classic stages, though not every patient experiences all phases.

1. Catarrhal stage (1–2 weeks)

• Runny nose, sneezing, mild low‑grade fever (≤38 °C / 100.4 °F)
• mild cough that resembles a common cold
• Conjunctival irritation (red eyes)

2. Paroxysmal stage (1–6 weeks, may last up to 10 weeks)

• Severe, sudden coughing fits (“paroxysms”) that may occur dozens of times per hour
• Characteristic high‑pitched “whoop” on inspiration after a cough bout (more common in children); adults may have a “gasp” instead
• Vomiting or gagging after coughing
• Facial flushing, exhaustion, and sometimes a brief loss of consciousness (rare)
• Nighttime coughing that interferes with sleep

3. Convalescent stage (2–12 weeks)

• Cough gradually wanes but may persist for months (the “post‑pertussis cough”)
• Episodes may be triggered by cold air, exercise, or respiratory infections

Note: Infants <6 months may not develop a whoop; instead, they present with apnea (brief pauses in breathing) and may look “blue” or limp after coughing. This presentation is a medical emergency.

Causes and Risk Factors

Pertussis is caused by infection with Bordetella pertussis, a Gram‑negative obligate aerobe that attaches to the ciliated epithelium of the trachea and bronchi, releasing toxins that impair ciliary function and cause inflammation.

Key risk factors

• Incomplete or waning immunity: Immunity after the DTaP (children) or Tdap (adolescents/adults) vaccine declines 5–10 years after the last dose.
• Infancy: Newborns have not completed the primary vaccine series and rely on maternal antibodies, which may be insufficient.
• Close contact with infected individuals: Household members, daycare centers, and schools are common transmission sites.
• Pregnancy: Women who have not received Tdap during each pregnancy are at higher risk and can transmit to newborns.
• Immunocompromised state: HIV, cancer chemotherapy, or chronic steroid use reduce the ability to clear infection.
• Living in areas with low vaccination coverage: Outbreaks frequently arise in communities with vaccine hesitancy.

Diagnosis

Diagnosis relies on a combination of clinical suspicion and laboratory confirmation.

Clinical assessment

• History of prolonged coughing spells, especially with a whooping sound.
• Typical progression through catarrhal → paroxysmal → convalescent stages.
• Exposure history (recent contact with a known case, lack of recent boosters).

Laboratory tests

1. PCR (polymerase chain reaction) of nasopharyngeal swab: Highly sensitive (≈95 %) during the first 3 weeks of illness. Specimen should be collected from the posterior nasopharynx with a flocked swab.
2. Culture: Gold standard but less sensitive (≈50–60 %) and requires special media (Regan‑Lowe agar). Results take 5–7 days.
3. Serology: Measurement of anti‑pertussis toxin IgG is useful >2 weeks after cough onset, especially when PCR is negative.

Additional work‑up (CBC, chest X‑ray) may be indicated to rule out secondary bacterial pneumonia or complications.

Treatment Options

Early treatment shortens the contagious period and may reduce symptom severity.

Antibiotic therapy

• Macrolides (first‑line): Azithromycin 10 mg/kg on day 1 then 5 mg/kg daily for 4 days, or a single 1 g dose in adults. Erythromycin 40–50 mg/kg/day divided q6h for 14 days is an alternative but has more GI side effects.
• Alternative agents: Trimethoprim‑sulfamethoxazole (TMP‑SMX) for macrolide‑resistant strains or contraindications.
• Antibiotics are most effective when started within 3 weeks of cough onset. After this window, they mainly reduce transmission.

Supportive care

• Maintain adequate hydration; offer frequent small sips of water or oral rehydration solutions.
• Humidified air (cool‑mist vaporizer) can ease airway irritation.
• Analgesics/antipyretics (acetaminophen or ibuprofen) for fever or discomfort.
• In severe cases, especially infants, hospitalization for respiratory support (oxygen, CPAP, or mechanical ventilation) may be required.

Lifestyle modifications

• Isolate from close contacts until 5 days after starting antibiotics (or 21 days if untreated).
• Encourage rest and avoid strenuous activity that triggers coughing.
• Elevate the head of the bed to reduce nighttime coughing.

Living with Pertussis (whooping cough)

Even after the acute phase, the cough can linger for months, affecting daily life.

Management tips

• Stay hydrated: Warm teas with honey (for children >1 year) soothe the throat.
• Honey & lemon: Natural demulcents that can reduce irritation.
• Use a humidifier: Keep humidity around 40–60 %.
• Avoid irritants: Smoke, strong fragrances, and cold air can trigger cough bouts.
• Gradual exercise: Light walking after meals; avoid high‑intensity workouts until coughing lessens.
• Vaccination of household members: Ensure Tdap boosters for all adults and adolescents to protect the patient (cocooning strategy).
• Follow‑up appointments: Usually 1–2 weeks after completing antibiotics to assess recovery and discuss persistent cough.

Prevention

Vaccination is the most effective tool.

Immunization schedule (U.S. CDC recommendations)

• DTP/DTaP series: 2, 4, 6, and 15–18 months, and a booster at 4–6 years.
• Tdap booster: Single dose at 11–12 years, then Td or Tdap every 10 years.
• Pregnant women: Tdap during 27–36 weeks of each pregnancy, regardless of prior vaccination status.

Additional measures

• Hand hygiene—wash hands with soap for at least 20 seconds.
• Avoid close contact with individuals who have a persistent cough, especially infants and the immunocompromised.
• Prompt treatment of suspected cases to limit spread.
• Consider “cocooning” – vaccinate parents, siblings, grandparents, and caregivers of newborns.

Complications

Complications are more common in infants, the elderly, and those with chronic lung disease.

• Pneumonia: Bacterial superinfection is the leading cause of pertussis‑related death.
• Apnea: Particularly in infants <6 months; can lead to hypoxia.
• Seizures: Result from hypoxia or fever.
• Encephalopathy: Rare, but reported in severe cases.
• Rib fractures: Due to violent coughing fits.
• Weight loss and dehydration: From prolonged vomiting and poor intake.

When to Seek Emergency Care

Prompt medical attention can be life‑saving, especially for infants and individuals with underlying health conditions.

References

• Centers for Disease Control and Prevention. Pertussis (Whooping Cough) – CDC. Updated 2024.
• Mayo Clinic. Whooping cough (pertussis) – symptoms and causes. 2023.
• World Health Organization. Pertussis – Global Surveillance. 2022.
• Cleveland Clinic. Whooping Cough Treatment & Prevention. 2024.
• National Institutes of Health, National Library of Medicine. Pertussis. MedlinePlus, 2024.